Pharmabiz

Onyx Scientific invests £1.5 million to expand commercial API production capacity at UK facility

Onyx Scientific invests £1.5 million to expand commercial API production capacity at UK facility: Newcastle, UK Wednesday, September 9, 2026, 12:00 Hrs [IST] Onyx Scientific, a g ...
Pharmabiz

Leucine Rich Bio launches enhanced BugSpeaks Skin Microbiome Test 2026 Edition

Leucine Rich Bio launches enhanced BugSpeaks Skin Microbiome Test 2026 Edition: Our Bureau, Bengaluru Wednesday, September 9, 2026, 10:00 Hrs [IST] Leucine Rich Bio, South Asia’ ...
Pharmabiz

Indian pharmaceutical market clocked 10.7% growth in August driven by price realization & Mounjaro surge

Indian pharmaceutical market clocked 10.7% growth in August driven by price realization & Mounjaro surge: Peethaambaran Kunnathoor, Chennai Wednesday, September 9, 2026, 08:00 Hrs ...
Pharmabiz

Expert asks NPPA to fix ceiling price for two early-stage breast cancer drugs abemaciclib and ribociclib

Expert asks NPPA to fix ceiling price for two early-stage breast cancer drugs abemaciclib and ribociclib: Our Bureau, New Delhi Wednesday, September 9, 2026, 08:00 Hrs [IST] The C ...
Pharmabiz

Fire safety must be embedded in healthcare design, not treated as an afterthought: Experts at FSIE 2026

Fire safety must be embedded in healthcare design, not treated as an afterthought: Experts at FSIE 2026: Shardul Nautiyal, Mumbai Wednesday, September 9, 2026, 08:00 Hrs [IST] Fir ...
Pharmabiz

Panel asks health ministry to mandate systematic pharmacoeconomic studies for widely prescribed Ayush drugs

The Department-related Parliamentary Standing Committee on Health and Family Welfare has recommended to the ministry of health to mandate systematic pharmacoeconomic studies for all widely prescribed ...
Pharmabiz

India’s speciality pharma push to depend on scientific innovation and effective manufacturing processes

India’s speciality pharma push to depend on scientific innovation and effective manufacturing processes: Nandita Vijayasimha, Bengaluru Wednesday, September 9, 2026, 08:00 Hrs [ ...
Opinion
PharmabizOpinion

A LAUDABLE INITIATIVE ON AMR

Obviously, it is a well thought out initiative as drug resistance cannot not be solved by guidelines alone. It can be solved at the patient's bedside, one clinical decision at a time. Those decisions ...
Pharmabiz

Ascletis Pharma initiates phase I study in US for oral amylin receptor peptide agonist ASC36 to treat obesity

Ascletis Pharma initiates phase I study in US for oral amylin receptor peptide agonist ASC36 to treat obesity: Hong Kong Wednesday, September 9, 2026, 13:00 Hrs [IST] Ascletis Pha ...
Pharmabiz

Novartis phase III HARBOR study of delpacibart etedesiran to treat myotonic dystrophy type 1 fails to meet primary endpoint

Novartis phase III HARBOR study of delpacibart etedesiran to treat myotonic dystrophy type 1 fails to meet primary endpoint: Basel Wednesday, September 9, 2026, 09:00 Hrs [IST] No ...
Pharmabiz

Clover Biopharma announces positive phase 2 data for RSV + hMPV ± PIV3 respiratory combination vaccine candidates in older adults

Clover Biopharma announces positive phase 2 data for RSV + hMPV ± PIV3 respiratory combination vaccine candidates in older adults: Shanghai Tuesday, September 8, 2026, 18:00 Hrs ...
Pharmabiz

Sun Pharmaceutical assigned preliminary 'BBB+' rating with stable Outlook: S&P Global Ratings

Sun Pharmaceutical assigned preliminary 'BBB+' rating with stable Outlook: S&P Global Ratings: Our Bureau, Mumbai Tuesday, September 8, 2026, 17:50 Hrs [IST] S&P Global Ratings as ...